POTELIGEO
Concentrate for solution for infusion, 4mg/ml
RxActive license
Active substance (INN)
mogamulizumab
Pharmaceutical form
Pharmaceutical formConcentrate for solution for infusion
Strength4mg/ml
PackagingUkupno 1 bočica staklena sa 5ml koncentrata za rastvor za infuziju u kartonskoj kutiji
Manufacturerallphamed PHARBIL Arzneimittel GmbH, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L01FX09)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateFebruary 28, 2024
Source: CInMED register